Randy H. Kardon, MD, PhD
Director, Center for the Prevention and Treatment of Visual Loss
He is the Director of Neuro-ophthalmology at The University of Iowa and has been an active clinician scientist for over 25 years. Additionally he is Director of the Iowa City VA Center for Prevention and Treatment of Vision Loss, funded by the Department of Veterans Affairs, which organizes a group of over 20 scientists and clinicians towards studying and researching optic nerve and retinal disorders that have relevance to the military population, especially in relation to traumatic brain injury (TBI). He has expertise in the physiology of the melanopsin containing retinal ganglion cells (MGC) in humans and in animals. Most recently, he has obtained funding and has published articles on using the pupil light reflex to measure the rod, cone, and melanopsin mediated pupil responses in humans and animals. Recently, they have extended their measurements to recording the EMG of the eye's squinting muscles and skin conductance in response to increasing intensities of red and blue light to objectively characterize photosensitivity in patients. Clinically, he also diagnose and works with patients and veterans with photophobia and headache following TBI. He has been collaborating with colleagues over the last few years on light mediated responses of the visual system. He also has a great deal of clinical expertise in photophobia and testing of visual function, including the pupil, besides my research and translational interests.
Laszlo L. Mechtler
Dent Neurologic Institute, Buffalo, NY
State University of New York at Buffalo, USA
Dr. László Mechtler is board certified in Neurology, Neuro-Oncology, Headache Medicine and Neuroimaging. He is a Professor of Neurology and Oncology at the State University of New York at Buffalo, the director of the Dent Headache and Neuro-Oncology Center and Chief of Neuro-Oncology at Roswell Park Cancer Institute. Dr. Mechtler's training includes institutions such as MD Anderson and the State University of New York at Buffalo. He is currently the Medical Director of the Dent Neurologic Institute (DNI) which is one of the largest neurological centers in the United States. He is the past President of the American Society of Neuroimaging (ASN) and the Hungarian Medical Association of America (HMAA). He has authored numerous publications and was the Editor of the 2009 and 2014 edition of Neurology Clinics. Dr. Mechtler is the current Associate Editor of Neuroimaging and Board Member of Continuum. He was appointed to sit on the State Athletic Medical Advisory Board by Governor Cuomo (2012-Current) and is on the Neuro-Expert Panel for the American College of Radiology (ACR). He was also recently appointed to sit on the executive committee for BrainPACs for the AAN. He has lectured both nationally and internationally and is presently the course director of Neuroimaging at the annual AAN Meeting.
Two-Photon Imaging Center, Institute of Experimental Medicine of Hungarian Academy of Sciences (IEM HAS), Budapest, Hungary
Balazs Rozsa is the leader of the Computational Neuroscience group at The Institute of Experimental Medicine of the Hungarian Academy of Sciences (IEM HAS). He is the leader of The Laboratory of 3D Functional Network and Dendritic Imaging, which is a multidisciplinary research team having laboratories at the IEM HAS Institute of Experimental Medicine of Hungarian Academy of Sciences - classified as a Center of Excellence by the European Commission and Pazmany Peter Catholic University (PPCU).
Two-Photon Imaging Center
Two-Photon Imaging Center
Faculty of Medicine, University of Basel, Basel, Switzerland
Botond Roska is the senior group leader at the Friedrich Miescher Institute for Biomedical Researchin Basel Switzerland, and project-leader for the National Centre of Competence in Research (NCCR) Molecular Systems Engineering, is a renowned expert in the structure and function of retinal circuits in health and disease. He is a graduate of Semmelweis University of Medicine, Budapest, and received his PhD from Department of Molecular and Cell Biology, University of California, Berkeley. His work has contributed in both a fundamental and highly original manner to our understanding of the function of retinal circuits. In addition, he has used his knowledge of retinal processing and the newly available optogenetic tools to reactivate retinal function, at least partially, in mouse models of blinding retinal diseases. Together with scientist from around the world, but particularly the Vision Institute in Paris, he currently tries to bring this method of vision restoration to patients with retinitis pigmentosa, and other late-onset adult blindness diseases. Professor Roska is the recipient of the prestigious 2016 Cogan Award from the Association of Research in Vision and Ophthalmology .